Scientific impact and technological consequences of the ICH E9(R1) Duration: 44 months (2023) Principal investigator(s): Mauro Gasparini Contract type: Commercial Research Structures DISMA - Department of Mathematical Sciences Partners GSK VACCINES S.R.L.
